Clincosm LogoSign in Get a demo

Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea

Sponsor
Asan Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT01477918
Collaborator
(none)
1,000
Enrollment
1
Location

Study Details

Study Description

Brief Summary

The aim of this study is to examine the prevalence of the Metabolic syndrome(MetS) in Korean patients with schizophrenia.

Primary objective:

• To investigate the prevalence of the MetS in Korean patients with schizophrenia

Secondary objectives:

• To compare the prevalence of the MetS among 3 groups according to antipsychotics: typical antipsychotic monotherapy group, atypical antipsychotic monotherapy group, 2 or more antipsychotics group (polypharmacy)

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1000 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Study Start Date :
    Dec 1, 2011

    Outcome Measures

    Primary Outcome Measures

    1. prevalence of metabolic syndrome (MetS) []

      MetS will be diagnosed according to NCEP ATP III with the Asian-Pacific abdominal obesity criterion (≥90 cm in men, ≥85 cm in women) 3 or more of the following criteria fasting plasma glucose >= 100 mg/dl or drug use to treat elevated glucose serum triglyceride (TG) >= 150 mg/dl or drug use to treat elevated TG HDL cholesterol level < 40mg /dl in males, < 50 mg/dl in female or drug use to treat low HDL Systolic BP >=130 mmHg, diastolic BP >=85 or drug use to treat hypertension Abdominal obesity : above described

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Diagnosis of schizophrenia according to DSM-IV-TR

    • Age between 18-65 years

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Asan medical center Seoul Korea, Republic of 138-736

    Sponsors and Collaborators

    • Asan Medical Center

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yeon-Ho Joo, Professor, Asan Medical Center
    ClinicalTrials.gov Identifier:
    NCT01477918
    Other Study ID Numbers:
    • MetS_1005
    First Posted:
    Nov 23, 2011
    Last Update Posted:
    Nov 23, 2011
    Last Verified:
    Nov 1, 2011
    Keywords provided by Yeon-Ho Joo, Professor, Asan Medical Center
    prevalence
    Korea
    Additional relevant MeSH terms:
    Metabolic Syndrome
    Syndrome
    Schizophrenia

    Study Results

    No Results Posted as of Nov 23, 2011